Lottery.com (LTRY) Competitors $0.33 +0.02 (+5.58%) (As of 02:20 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends LTRY vs. VINC, STRM, DTSS, MMV, HRYU, BLIN, VRAR, IPDN, LCFY, and EVOLShould you be buying Lottery.com stock or one of its competitors? The main competitors of Lottery.com include Vincerx Pharma (VINC), Streamline Health Solutions (STRM), Datasea (DTSS), MultiMetaVerse (MMV), Hanryu (HRYU), Bridgeline Digital (BLIN), The Glimpse Group (VRAR), Professional Diversity Network (IPDN), Locafy (LCFY), and Symbolic Logic (EVOL). Lottery.com vs. Vincerx Pharma Streamline Health Solutions Datasea MultiMetaVerse Hanryu Bridgeline Digital The Glimpse Group Professional Diversity Network Locafy Symbolic Logic Lottery.com (NASDAQ:LTRY) and Vincerx Pharma (NASDAQ:VINC) are both small-cap consumer discretionary companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, community ranking, institutional ownership, media sentiment, valuation, risk, earnings, analyst recommendations and profitability. Which has more risk & volatility, LTRY or VINC? Lottery.com has a beta of 1.3, indicating that its share price is 30% more volatile than the S&P 500. Comparatively, Vincerx Pharma has a beta of 1.6, indicating that its share price is 60% more volatile than the S&P 500. Does the MarketBeat Community prefer LTRY or VINC? Vincerx Pharma received 19 more outperform votes than Lottery.com when rated by MarketBeat users. Likewise, 65.63% of users gave Vincerx Pharma an outperform vote while only 50.00% of users gave Lottery.com an outperform vote. CompanyUnderperformOutperformLottery.comOutperform Votes250.00% Underperform Votes250.00% Vincerx PharmaOutperform Votes2165.63% Underperform Votes1134.38% Is LTRY or VINC more profitable? Vincerx Pharma has a net margin of 0.00% compared to Lottery.com's net margin of -505.07%. Lottery.com's return on equity of -74.33% beat Vincerx Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Lottery.com-505.07% -74.33% -43.74% Vincerx Pharma N/A -248.33%-132.73% Does the media refer more to LTRY or VINC? In the previous week, Vincerx Pharma had 1 more articles in the media than Lottery.com. MarketBeat recorded 4 mentions for Vincerx Pharma and 3 mentions for Lottery.com. Lottery.com's average media sentiment score of 0.54 beat Vincerx Pharma's score of -0.09 indicating that Lottery.com is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lottery.com 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Vincerx Pharma 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate LTRY or VINC? Vincerx Pharma has a consensus target price of $2.00, indicating a potential upside of 654.15%. Given Vincerx Pharma's stronger consensus rating and higher possible upside, analysts plainly believe Vincerx Pharma is more favorable than Lottery.com.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lottery.com 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Vincerx Pharma 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger earnings & valuation, LTRY or VINC? Lottery.com has higher revenue and earnings than Vincerx Pharma. Vincerx Pharma is trading at a lower price-to-earnings ratio than Lottery.com, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLottery.com$6.48M0.51-$25.47M-$9.62-0.03Vincerx PharmaN/AN/A-$40.16M-$1.03-0.26 Do institutionals & insiders hold more shares of LTRY or VINC? 7.7% of Lottery.com shares are owned by institutional investors. Comparatively, 44.0% of Vincerx Pharma shares are owned by institutional investors. 19.9% of Lottery.com shares are owned by company insiders. Comparatively, 17.2% of Vincerx Pharma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. SummaryVincerx Pharma beats Lottery.com on 10 of the 17 factors compared between the two stocks. Ad Insiders Exposed917 Trades… Zero Losses?As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”Go here to see how you can start accessing these opportunities today Get Lottery.com News Delivered to You Automatically Sign up to receive the latest news and ratings for LTRY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LTRY vs. The Competition Export to ExcelMetricLottery.comPrepackaged software IndustryDiscretionary SectorNASDAQ ExchangeMarket Cap$3.34M$25.55B$8.40B$8.84BDividend YieldN/A2.26%2.77%4.07%P/E Ratio-0.0364.9515.5514.22Price / Sales0.519.357.8288.42Price / CashN/A87.8033.2236.27Price / Book0.038.803.676.37Net Income-$25.47M$444.73M$265.65M$225.56M7 Day Performance6.27%2.43%-0.72%-0.02%1 Month Performance-35.82%6.93%-1.18%2.04%1 Year Performance-81.92%27.23%16.32%28.00% Lottery.com Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LTRYLottery.com0.7937 of 5 stars$0.33+5.6%N/A-83.1%$3.34M$6.48M-0.0350Gap UpVINCVincerx Pharma2.9731 of 5 stars$0.27-3.8%$2.00+654.1%-60.6%$8.90MN/A0.0060STRMStreamline Health Solutions1.5884 of 5 stars$3.11+6.5%N/A-35.1%$13.12M$22.60M-0.59130Analyst ForecastDTSSDatasea1.638 of 5 stars$2.46-2.4%N/A-15.2%$12.67M$23.98M0.00120MMVMultiMetaVerseN/A$0.37+4.7%N/A-75.5%$12.23M$9.01M0.0081HRYUHanryu0.1776 of 5 stars$0.22-2.3%N/A-55.6%$11.61M$790,000.000.0074Gap DownBLINBridgeline Digital1.256 of 5 stars$1.09+0.0%N/A+48.6%$11.36M$15.89M-1.2060News CoverageVRARThe Glimpse Group2.7846 of 5 stars$0.60-0.8%$2.65+341.6%-51.2%$10.90M$8.80M0.00112IPDNProfessional Diversity Network0.8023 of 5 stars$0.73flatN/A-43.0%$9.59M$7.70M0.0040Analyst ForecastNews CoverageLCFYLocafy0.9045 of 5 stars$6.72-0.4%N/A+8.9%$9.29M$3.85M-5.4950Gap DownEVOLSymbolic LogicN/A$0.85flatN/A+4.3%$9.07MN/A0.008Analyst ForecastNews Coverage Related Companies and Tools Related Companies Vincerx Pharma Competitors Streamline Health Solutions Competitors Datasea Competitors MultiMetaVerse Competitors Hanryu Competitors Bridgeline Digital Competitors The Glimpse Group Competitors Professional Diversity Network Competitors Locafy Competitors Symbolic Logic Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LTRY) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lottery.com Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lottery.com With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
